Lv1
10 积分 2024-02-23 加入
Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy
3个月前
已完结
Epidemiological characteristics and clinical analyses of chronic cutaneous wounds of inpatients in China: Prevention and control
3个月前
已完结
Epidemiology of chronic cutaneous wounds in China
3个月前
已完结
Epidemiological study of chronic dermal ulcers in China
3个月前
已完结
痛风创面的综合治疗
4个月前
已完结
Jinlida for Diabetes Prevention in Impaired Glucose Tolerance and Multiple Metabolic Abnormalities: The FOCUS Randomized Clinical Trial
5个月前
已完结
The traditional Chinese medicine Qiliqiangxin in heart failure with reduced ejection fraction: a randomized, double-blind, placebo-controlled trial
5个月前
已完结
A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of the effects of qili qiangxin capsules in patients with chronic heart failure
5个月前
已完结
肛瘘诊治中国专家共识
5个月前
已完结
Efficacy and safety of Chinese herbal medicine children's Zibei Xuanfei syrup in treating acute trachea-bronchitis with wind-heat invading lung syndrome: A randomized, double-blind, multicentre, controlled trial
5个月前
已完结
皖公网安备34019202002308
